Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
The FLOW trial investigated the effects of semaglutide on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease, revealing significant reductions in cardiovascular death, myocardial infarction, and stroke.
This study evaluated the impact of telemedicine-assisted structured self-monitoring of blood glucose on glycemic control in adults with type 2 diabetes, finding significant improvements in HbA1c and other metrics.
This study explored participants' experiences with a telemonitoring intervention for Type 2 Diabetes, finding high satisfaction and improved lifestyle behaviors.
The study investigated the effects of tirzepatide on HbA1c levels, highlighting the role of weight loss in these reductions.
This study investigated the effects of vitamin D supplementation on inflammatory factors in patients with type 2 diabetes, finding significant reductions in certain inflammatory markers.
This study investigated the effects of vitamin D supplementation on glycemic control in newly diagnosed type 2 diabetes patients. No significant differences were found between the vitamin D group and the standard anti-diabetic drugs group.
The study evaluated the Complete Health Improvement Program (CHIP) against usual care in a randomized-controlled trial. Results indicated improvements in HbA1c and waist circumference for the intervention group.
This study tested a community lifestyle programme for adults with prediabetes in Malaysia. After 12 months, people in the programme had lower blood sugar, better cholesterol, smaller waists, and improved quality of life compared to those receiving usual care. The programme was delivered through existing community volunteers.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
